01:26 PM EST - Gemina Laboratories Ltd : Announces that it has entered into agreement with International Point of Care, Inc, for the manufacturing of its Legio XTM COVID-19 Rapid Antigen Test. The agreements signed today include both a Manufacturing and Supply Agreement and a License Agreement setting out the terms upon which IPOC will manufacture the Legio XTM Test in Canada to satisfy demand from distributors in CE Mark eligible jurisdictions. Gemina Laboratories Ltd
shares C.GLAB are trading unchanged at $0.47.
